The Patent Finder
US

Monospecific and Bispecific ANTI-IGF-1R and ANTI-ERBB3 Antibodies

US 9,527,914 Lapsed on the fee record
OverviewFamilyAssignmentsSources & methods

Lapsed Dec 27, 2020 on the fee record · Medium confidence

Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 9,556,274), so the cap could be lower.

First maintenance fee unpaid; grace period ended.

Filed Sep 17, 2015 as application 14/857,344 · Granted Dec 27, 2016
Base term, 20 years from filing
Today
Lapsed Dec 27, 2020
2012 2032
Clock starts
Apr 19, 2012
No longer in force
Dec 27, 2020
Granted
Dec 27, 2016
Term would have run to
Apr 19, 2032
base term after the term ends Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,476,409, US 9,556,274, to Apr 19, 2032. The term already ends on or before that date, so the cap shortened nothing.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

Its term would have run to Apr 19, 2032: its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Apr 19, 2012, when application 13/451,135, the earliest non-provisional in its chain, was filed (this one was filed Sep 17, 2015)Apr 19, 2032High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 8,476,409, US 9,556,274)resolves to Apr 19, 2032, no earlier than this term, so no changeMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidlapsed Dec 27, 2020High confidence
Computed term endThe steps above, in orderDec 27, 2020Medium confidence

This family

US 8,476,409In force
Apr 2032
Apr 2032
US 9,556,274Lapsed on the fee record
Jan 2021
Jan 2021
US 9,527,914this patent
Dec 2020
Dec 2020
US 9,938,346In force
Apr 2032
Apr 2032
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Dec 28, 2015
Reel 37394, frame 285
Merrimack Pharmaceuticals, Inc.U.S. Bank National Association, as Collateral AgentSecurity Interest
Aug 24, 2016
Reel 39519, frame 52
Baum, Jason; Johnson, Bryan; Lugovskoy, Alexey Alexandrovich; Xu, Lihui; Kohli, Neeraj; Fitzgerald, Jonathan Basil; Adams, SharleneMerrimack Pharmaceuticals, Inc.Assignment of Assignor's Interest
Apr 14, 2017
Reel 42254, frame 349
U.S. Bank National AssociationMerrimack Pharmaceuticals, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited